Skip to main content
. 2014 Jan 21;5(3):659–666. doi: 10.18632/oncotarget.1597

Table 6. Polypharmacology of currently approved anticancer drugs.

Drug Indication Drug Bank Targets PubChem Off-Target
Sunitinib renal cell carcinoma 8 ~150
Sorafenib advanced renal cell carcinoma, liver cancer 7 ~120
Tamoxifen breast cancer 2 ~70
Paclitaxel lung, ovarian, and breast cancer 2 4